Adenoviral Gene Transfer of the Human Inducible Nitric Oxide Synthase Gene Enhances the Radiation Response of Human Colorectal Cancer Associated with Alterations in Tumor Vascularity

Cancer Research

Volumn 64, Issue 4, 2004, Pages 1386-1395

  Wang, Zifa ^a   Cook, Tracy ^a   Alber, Sean ^a   Liu, Kaihong ^a   Kovesdi, Imre ^b   Watkins, Simon K ^a   Vodovotz, Yoram ^a   Billiar, Timothy R ^a   Blumberg, David ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b GENVEC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INDUCIBLE NITRIC OXIDE SYNTHASE GENE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; TUMOR VASCULARIZATION;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL CYCLE; COLORECTAL NEOPLASMS; GENE THERAPY; GENE TRANSFER, HORIZONTAL; HUMANS; MICE; MICE, NUDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RADIATION TOLERANCE;

EID: 1242338769     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1307     Document Type: Article

References (42)

1. Heald, R. J., Husband, E. M., and Ryall, R. D. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?. Br. J. Surg., 69: 613-616, 1982.
2. Quirke, P., Durdey, P., Dixon, M. F., and Williams, N. S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet, 2: 996-999, 1986.
3. Minsky, B. D., Cohen, A. M., Enker, W. E., and Sigurdson, E. Phase I/II trial of per-operative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 23: 387-392, 1992.
4. Hyams, D. M., Mamounas, E. P., Petrelli, Rockette, H., Jones, J., Wieand, H. S., Deutsch, M., Wickerman, L., Fisher, B., and Wolmark, N. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Adjuvant Breast and Bowel Project Protocol R-03. Dis. Colon Rectum, 40: 131-139, 1997.
5. Mehta, V. K., Poen, J., Ford, J., Edelstein, P. S., Vierra, M., Bastidas, A. J., et al. Radiotherapy, concomitant protracted-venous infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer. Dis. Colon. Rectum., 44: 52-58, 2001.
6. Read, T. E., McNevin, M. S., Gross, E. K., Whiteford, H. M., Lewis, J. L., Ratkin, G., et al. Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity. Dis. Colon Rectum, 44: 513-522, 2001.
7. Meade, P. G., Blatchford, G. J., Thorson, A. G., Christensen, M. A., and Ternent, C. A. Preoperative chemoradiation downstages locally advanced ultrasound-staged rectal cancer. Am. J. Surg., 170: 609-613, 1995.
8. Bouzourene, H., Bosman, F. T., Seelentag, W., Matter, M., and Coucke, P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer, 94: 1121-1130, 2002.
9. Minsky, B. D., Cohen, A. M., Enker, W. E., Saltz, L., Guillem, J. G., Paty, P. B., Kelsen, D. P., Kemeny, N., Ilson, D., Bass, J., and Conti, J. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int. J. Radat. Oncol. Biol. Phys., 37: 289-295, 1997.
10. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064, 1992.
11. Graziewicz, M., Wink, D. A., and Laval, F. Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage. Carcinogenesis (Lond.), 17: 2501-2505, 1996.
12. Kurimoto, M., Endo, S., Hirashima, H., Ogiichi, T., and Takaku, A. Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents. J. Neurooncol., 42: 35-44, 1999.
13. Mitchell, J. B., Wink, D. A., DeGraff, W., Gamson, J., Keefer, L. K., and Krishna, M. C. Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res., 53: 5845-5848, 1993.
14. Griffin, R. J., Makepeace, C. M., Hur, W. J., and Song, C. W. Radiosensitizing of hypoxic tumor cells in vitro by nitric oxide. Int. J. Radiat. Oncol. Biol. Phys., 36: 377-383, 1996.
15. Geller, D. A., Lowenstein, C. J., Shapiro, R. A., Nussler, A. K., Di Silvio, M., Wang, S. C., Nakayama, D. K., Simmons, R. L., Snyder, S. H., and Billiar, T. R. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA, 90: 349-355, 1993.
16. Kibbe, M. R., Nie, S., Yoneyama, T., Hatakeyama, K., Lizonova, A., Kovesdi, I., Billiar, T. R., and Tzeng, E. Optimization of ex-vivo inducible nitric oxide synthase gene transfer to vein grafts. Surgery, 126: 323-329, 1999.
17. Chung, P., Cook, T., Liu, K., Vodovotz, Y., Zamora, R., Finkelstein, S., Billiar, T., and Blumberg, D. Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism. Nitric Oxide, 8: 119-126, 2003.
18. Miranda, K. M., Espey, M. G., and Wink, D. A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide, 5: 62-71, 2001.
19. Russo, A., Mitchell, J. B., DeGraff, W., Spiro, I., and Gamson, J. The effects of cellular glutathione elevation on the oxygen enhancement ratio. Radiat. Res., 103: 232-239, 1985.
20. Del Bino, G., Darzynkiewicz, Z., Degraef, C., Mosselmans, R., Fokan, D., and Galand, P. Comparison of methods based on annexin-V binding, DNA content or TUNEL for evaluating cell death in HL-60 and adherent MCF-7 cells. Cell Prolif., 32: 25-37, 1999.
21. Kijima, T., Niwa, H., Steinman, R. A., Drenning, S. D., Gooding, W. E., Wentzel, A. L., Xi, S., and Grandis, J. R. STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo. Cell Growth Differ., 13: 355-362, 2002.
22. Lee, P. C., Kibbe, M. R., Schuchert, M. J., Stolz, D. B., Watkins, S. C., Griffith, B.P., et al. Nitric oxide induces angiogenesis and upregulates alphav-beta3 integrin expression on endothelial cells. Microvasc. Res., 60: 269-280, 2000.
23. Chastagner, P., Merlin, J. L., Marchal, C., Hoffstetter, S., Barberi-Heyob, M., Vassal, G., and Duprez, A. In vivo radiopotentiation of radiation response by topetecan in human rhabdomyosarcoma xenografted into nude mice. Clin. Cancer Res., 6: 3327-3333, 2000.
24. Ambs, S., Merriam, W. G., Ogunfusika, M. O., Bennett, W. P., Ishibe, N., Hussain, S. P., Tzeng, E. E., Geller, D. A., Billiar, T. R., and Harris, C. C. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat. Med., 4: 1371-1376, 1998.
25. Jordan, B. F., Misson, P., Demeure, R., Baudelet, C., Beghein, N., and Gallez, B. Changes in tumor oxygenation/perfusion induced by the NO donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI. Int. J. Radiat. Oncol. Biol. Phys., 48: 565-570, 2000.
26. Soler, M. N., Bobe, P., Benihoud, K., Lemaire, G., Roos, B. A., and Lausson, S. Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection. J. Gene Med., 2: 344-352, 2000.
27. Khare, P. D., Shao-Xi, L., Kuroki, M., Hirose, Y., Arakawa, F., Nakamura, K., et al. Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase. Cancer Res., 61: 370-375, 2001.
28. Xu, W., Liu, L., and Charles, I. G. Microencapsulated iNOS-expressing cells cause tumor suppression in mice. FASEB J., 16: 213-215, 2002.
29. Worthington, J., Robson, T., O'Keefe, M., and Hirst, D. G. Tumor cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy. Gene Ther., 9: 263-269, 2002.
30. Buchholz, D. J., Lepek, K. J., Rich, T. A., and Murray, D. 5-Fluorouracil-radiation interactions in human colon adenocarcinoma cells. Int. J. Radiat. Oncol. Biol. Phys., 32: 1053-1058, 1995.
31. Lawrence, T. S., Davis, M. A., and Maybaum, J. Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects. Int. J. Radiat. Oncol. Biol. Phys., 29: 519-523, 1994.
32. Omura, M., Torigoe, S., and Kubota, N. SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids. Radiother. Oncol., 43: 197-201, 1997.
33. Mehta, V. K., Cho, C., Ford, J. M., Jambalos, C., Poen, J., Koong, A., Lin, A., Bastidas, J. A., Young, H., Dunphy, E. P., and Fisher, G. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 55: 132-137, 2003.
34. Spitz, F. R., Nguyen, D., Skibber, J. M., Meyn, R. E., Cristiano, R. J., and Roth, J. A. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin. Cancer Res., 2: 1665-16671, 1996.
35. Williams, K. J., Telfer, B. A., Statford, I. J., and Wedge, S. R. ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model. Br. J. Cancer, 86: 1157-1161, 2002.
36. Pyo, H., Choy, H., Amorino, G. P., Kim, J. S., Cao, Q., Hercules, S. K., and Dubois, R. N. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin. Cancer Res., 10: 2998-3005, 2001.
37. Sonveaux, P., Dessy, C., Brouet, A., Jordan, B. F., Gregoire, V., Gallez, B., Balligand, J. L., and Feron, O. Modulation of the tumor vasculature functionality by ionizing irradiation accounts for tumor radiosensitivity and promotes gene delivery. FASEB J., 16: 1979-1981, 2002.
38. Yang, Y., Greenough, K., and Wilson, J. M. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther., 3: 412-420, 1996.
39. Ye, X., Robinson, M. B., Pabin, C., Batshaw, M. L., and Wilson, J. M. Transient depletion of the CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse. Gene Ther., 7: 1761-1767, 2000.
40. Lawrence, T. S., Davis, M. A., Hough, A., and Rehermulla, A. The role of apoptosis in 2′2′-difluoro-2′-deoxycytidine (Gemcitabine)-mediated radiosensitization. Clin. Cancer Res., 7: 314-319, 2001.
41. waf/cip1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. Cancer Res., 60: 679-684, 2000.
42. Kuninaka, S., Ichinose, Y., Koja, K., and Toh, Y. Suppression of manganese superoxide dismutase augments the sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis. Br. J. Cancer, 83: 928-934, 2000.